Cirrus Therapeutics
Breakthrough Gene Therapy for Dry AMD
Boston, United States · $11.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Business Model
- B2B
- Website
- cirrustx.com
- Total Funding
- $11.0M
- Last Round
- $11.0M SeedOct 2025
- Rounds
- 1
About
Ocular immunology company developing groundbreaking therapies for age-related macular degeneration and other retinal diseases.
Summary
Cirrus Therapeutics is a Biotech company based in Boston, United States. It has raised $11.0M in total across 1 round, most recently a $11.0M Seed round in Oct 2025. Investors include Polaris Partners, Polaris Innovation Fund and ClavystBio.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Oct 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...